More articles about Glaxosmithkline

May 15, 2013

Is Vivus a Buy at These Prices?

Vivus is a biopharmaceutical company that is attacking issues negatively affecting many American people. The stock has not done too well lately but may be currently stabilizing from a recent rise in selling.

May 05, 2013

Can Johnson & Johnson Deal With This Publicity Fiasco?

Another publicity nightmare for a company that has had to smooth over things with customers after numerous recalls...

May 02, 2013

Opko Health CEO Buys 45K Shares and 4 Insider Trades to Note

Take a closer look at the inside executive action of these companies...

April 23, 2013

Will GlaxoSmithKline Continue To Explode?

GlaxoSmithKline provides essential pharmaceutical products to consumers in need offering a range of treatments worldwide. The stock has not done very well as it has been a part of a downtrend for the last several years...

April 16, 2013

4 Healthcare Stock Stories For Tuesday Investment Wellness

Analysis of Top healthcare Business News: 4 Healthcare Stock Stories For Tuesday Investment Wellness

April 16, 2013

DTE Energy Wins Best of the Best and 2 More Stocks at 52-Week Highs

See which stocks hit 52-week highs on a very down day...

April 15, 2013

Is Merck Overvalued?

Merck has been performing well year-to-date. Is this trend likely to continue?

April 13, 2013

3 Health Stocks That Ended The Week On A Bad Note

A couple of drug companies have grim outlooks thanks to patents expiring on popular drugs, while one company's innovation has come under heavy scrutiny. All three face tough times ahead...